Japanese researchers have used CRISPR gene-editing tools to remove the entire extra chromosome 21 from lab-grown cells. The results hint at future possibilities for understanding and potentially addressing the root cause of Down syndrome, but they also raise important questions about science, ethics, and the limits of genetic technology.
Looking for Something Else Today?
From Italy to a Nasdaq Reservation
How do you follow record-setting success? Get stronger. Take Pacaso. Their real estate co-ownership tech set records in Paris and London in 2024. No surprise. Coldwell Banker says 40% of wealthy Americans plan to buy abroad within a year. So adding 10+ new international destinations, including three in Italy, is big. They even reserved the Nasdaq ticker PCSO.
Paid advertisement for Pacaso’s Regulation A offering. Read the offering circular at invest.pacaso.com. Reserving a ticker symbol is not a guarantee that the company will go public. Listing on the NASDAQ is subject to approvals.






